Paracetamol has been the first-line analgesic and antipyretic of choice in UK pregnancy for decades. Over the past few years a body of observational research — and the media coverage that followed — has made more pregnant women at the pharmacy counter anxious about taking it. This is a careful look at where the UK guidance actually stands in 2026, what the evidence debate does and does not show, and how a UK community pharmacy frames the conversation.
The UK position, plainly
The NHS, the Royal College of Obstetricians and Gynaecologists (RCOG), the Medicines and Healthcare products Regulatory Agency (MHRA), and UKTIS (the UK Teratology Information Service, which sits behind the Best Use of Medicines in Pregnancy service) all continue to state in 2026 that:
- Paracetamol is the first-line analgesic and antipyretic for use in pregnancy.
- It should be used at the lowest effective dose for the shortest duration needed.
- Uncontrolled fever and pain in pregnancy themselves carry risks — treatment is not a cosmetic decision.
The formal UKTIS Best Use of Medicines in Pregnancy monograph reflects this, and NHS patient-facing information is consistent.
What the recent debate is about
A 2021 consensus statement in Nature Reviews Endocrinology authored by an international group of researchers, drawing on observational studies of in-utero paracetamol exposure and subsequent neurodevelopmental and reproductive outcomes, called for precautionary use. Further observational research has continued to appear since.
The UK regulatory and professional response, through UKTIS, RCOG and the MHRA, has been measured:
- Observational studies cannot establish causation. Confounding by indication — the underlying reason paracetamol was taken (fever, infection, migraine) may itself influence outcomes — is difficult to eliminate.
- A large sibling-controlled Swedish study published in 2024 found no association between paracetamol exposure in pregnancy and ADHD or autism once familial factors were adjusted for. Sibling designs reduce some but not all confounding.
- Uncontrolled pyrexia in the first trimester is a known independent risk factor for congenital abnormality. Treating fever is not optional advice.
The UK guidance therefore sits in a specific position: take the concerns seriously enough to use the minimum necessary, do not take them so seriously that you leave treatable pain or fever untreated.
What the UK pharmacy says at the counter
A UK community pharmacy typically frames paracetamol in pregnancy as:
- First choice for mild-to-moderate pain and fever at any stage of pregnancy
- Use the lowest effective dose for the shortest time — UKTIS language
- Standard adult dose applies — 500 mg–1 g every 4–6 hours, maximum 4 g in 24 hours
- If you find you need it most days for more than a short period, speak to your GP or midwife — both about the underlying problem and the analgesic approach
The phrase "use the lowest effective dose for the shortest time" is not a hedge — it is standard therapeutic advice for any analgesic in pregnancy, and it applies to paracetamol, ibuprofen (where suitable) and codeine (generally avoided in pregnancy) equally.
What pregnant women should not take
The counter conversation about paracetamol in pregnancy is often, in practice, a conversation about what not to use. UK guidance:
- NSAIDs (ibuprofen, naproxen, diclofenac): avoid from 20 weeks, contraindicated from 30 weeks — associated with premature closure of the fetal ductus arteriosus and oligohydramnios. Before 20 weeks, occasional short courses are used with caution, but paracetamol remains preferred.
- Aspirin at analgesic doses: avoid. Low-dose aspirin (75–150 mg) for pre-eclampsia prophylaxis is different and prescribed by the obstetric team.
- Codeine and dihydrocodeine: generally avoided in pregnancy, particularly near term, because of concerns about neonatal opioid exposure and withdrawal.
Paracetamol is essentially the only simple analgesic that remains first-line throughout pregnancy.
Context: untreated pain and fever are not harmless
It is worth saying clearly at the counter: migraines that are untreated can be severe enough to cause dehydration and vomiting; fever in the first trimester carries its own risks; musculoskeletal pain that is untreated affects sleep and mental health. The risk-benefit framing is not "paracetamol vs nothing." It is "paracetamol at minimum necessary dose vs the underlying symptom."
The RCOG and UKTIS framing
The RCOG's patient information and UKTIS's Best Use of Medicines in Pregnancy factsheets are the most authoritative UK-facing documents. A pharmacy that is asked a detailed question beyond counter scope can reasonably signpost to UKTIS: https://www.medicinesinpregnancy.org/. The site has plain-language monographs on paracetamol and on the specific conditions around it.
When to refer rather than reach for paracetamol
- Headache with visual disturbance, upper abdominal pain, sudden swelling — possible pre-eclampsia, same-day midwife or obstetric review
- Fever without obvious source in a pregnant woman — same-day GP or midwife review
- Persistent headache that does not respond to a first dose — GP review rather than escalation to other analgesics
- Any pain accompanied by reduced fetal movements
Summary
The UK's 2026 position on paracetamol in pregnancy is stable and careful. It is the first-line analgesic, it should be used at the minimum necessary dose for the minimum necessary duration, and it is — by a significant margin — the safest routinely-available analgesic across all three trimesters. The evidence debate is real but the conclusion at the counter is unchanged.
See our heartburn in pregnancy guide and nausea in pregnancy guide for related counter topics.
Sources
- NHS — Medicines in pregnancy
- Royal College of Obstetricians and Gynaecologists
- UKTIS — Best Use of Medicines in Pregnancy
- British National Formulary — Paracetamol monograph
General information for UK pharmacy customers. Decisions about medicines in pregnancy should be confirmed with your pharmacist, GP or midwife.